There were 1,248 press releases posted in the last 24 hours and 412,693 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Enrollment begins for Sanofi and GSK’s Phase 3 efficacy trial of COVID-19 vaccine candidate in Nepal, led by IVI

TO:
Aerie Em
International Vaccine Institute
+82 2-881-1386

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image